PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Overview Fund Activity
Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

51 hedge funds and large institutions have $7.97M invested in Pear Therapeutics, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+6
Holders Change %
+13.33%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
4
Closed
3
Calls
$2.78M
Puts
–
Net Calls
+$2.78M
Net Calls Change
+$20K

Top Buyers

1
BCM
BlueCrest Capital Management
Jersey
$317K
2
MF
Magnetar Financial
Illinois
$262K
3
SRF
Silver Rock Financial
California
$186K
4
AGM
Alpine Global Management
New York
$301K
5
LP
LMR Partners
United Kingdom
$617K

Top Sellers

1
LA
Linden Advisors
New York
$0
2
PC
Periscope Capital
Ontario, Canada
$45K
3
WP
Woodline Partners
California
$0
4
CAC
Cowen and Company
New York
$0
5
Verition Fund Management
Verition Fund Management
Connecticut
$106K
Name Holding Trade Value Shares
Change 		Shares
Change %
LA
51
Linden Advisors
New York
– -$237K -165,114 Closed
WP
52
Woodline Partners
California
– -$70K -50,034 Closed
CAC
53
Cowen and Company
New York
– -$22K -15,000 Closed
1 2
3